- Analysts
- Dividend Payments
- Government Awards
- Insiders
- Lobbying Expenses
- Segment Revenues
- Shareholder Structure
- Supply / Portfolio
- Valuation Models [Soon]
- Board & Officers
- Business Intelligence
- Employee Voice
- ESG Scores [Soon]
- Mergers and Acquisitions
- Qualified Risks
- Clinical Trials [Soon]
- H1B/PERM Strategy
- Industry H&T [Soon]
- Macro
- News
- Patents / Trademarks [Soon]
- Peer Performance
- Relevant Disputes [Soon]
Organogenesis Holdings Inc.
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products inclu…
Shareholders
Major Shareholders · StructureBreakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Organogenesis Holdings Inc.
Beneficial Owners Beta
Beneficial owners who control a significant portion of the shares outstanding.
| Owner | Shares | Equivalence - $3.23 per share | Last Form/Filing | Last Transaction |
|---|---|---|---|---|
| 10% Holder | ||||
| - No data - | ||||
| Officers/Directors Below 10% | ||||
| - No data - | ||||
Shareholder Breakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public.
It's perfect to get a quick briefing regarding the shareholder structure of Organogenesis Holdings Inc.
Short
We source Fail-To-Deliver data every month, directly from the SEC.